How do the many tools for investigating and treating pulmonary embolism fit into one coherent pathway? This 2014 discussion explores the challenge of combining diagnostic rules, risk assessment and outpatient care, as work began on British Thoracic Society guidance for ambulatory management.
Ambulatory PE: A walk in the park? St.Emlyn’s Read More
Who needs thromboprophylaxis after lower-limb immobilisation? This 2012 discussion introduces College of Emergency Medicine guidance, considers the evidence for ambulatory trauma patients and argues for individual VTE risk assessment rather than treating every plaster cast in the same way.
The POP, the Chief, his risk assessment and her thromboprophylaxis Read More
Could the ADAPT protocol identify chest-pain patients suitable for earlier discharge? This 2012 appraisal examines its combination of risk scoring and serial troponin testing, then questions symptom timing, external validation, assay choice and how many patients might actually avoid further investigation.
Low risk chest pain? ADAPT my management? Read More
Did the 6S trial change the case for starch-based resuscitation fluids? This 2012 journal club reviews hydroxyethyl starch versus Ringer’s acetate in severe sepsis, examining randomisation, blinding and the mortality findings, and asking how the results should influence interpretation of the crystalloid–colloid debate.
JC: The end for potatoes on the ICU…? Read More
Should superficial venous thrombosis be observed or treated with anticoagulation? This 2012 discussion considers what ultrasound adds, unpacks the composite outcome in CALISTO and weighs treatment benefits against bleeding and burden, emphasising the importance of explaining uncertainty when making decisions with patients.
Superficial Venous Thrombosis: watch and wait or anticoagulate? Read More
